Cargando…
Utility of Smart Arc CDR for intensity-modulated radiation therapy for prostate cancer
Volumetric-modulated arc therapy (VMAT) is a widespread intensity-modulated radiation therapy (IMRT) method, however, VMAT requires adaptation of the radiation treatment planning system (RTPS) and linear accelerator (linac); these upgrades are quite expensive. The Smart Arc of Pinnacle(3) (Philips),...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099990/ https://www.ncbi.nlm.nih.gov/pubmed/24522268 http://dx.doi.org/10.1093/jrr/rrt232 |
_version_ | 1782326589698080768 |
---|---|
author | Hatanaka, Shogo Tamaki, Seiichi Endo, Haruna Mizuno, Norifumi Nakamura, Naoki |
author_facet | Hatanaka, Shogo Tamaki, Seiichi Endo, Haruna Mizuno, Norifumi Nakamura, Naoki |
author_sort | Hatanaka, Shogo |
collection | PubMed |
description | Volumetric-modulated arc therapy (VMAT) is a widespread intensity-modulated radiation therapy (IMRT) method, however, VMAT requires adaptation of the radiation treatment planning system (RTPS) and linear accelerator (linac); these upgrades are quite expensive. The Smart Arc of Pinnacle(3) (Philips), which is the software used in VMAT calculations, can select constant dose rate (CDR) mode. This approach has a low initial cost because the linac upgrade is not required. The objective of this study was to clarify the utility of CDR mode for prostate IMRT. Pinnacle(3) and Clinac 21EX linac (Varian, 10 MV X-rays) were used for planning. The plans were created for 28 patients using a fixed multi-field IMRT (f-IMRT), VMAT and CDR techniques. The dose distribution results were classified into three groups: optimal, suboptimal and reject. For the f-IMRT, VMAT and CDR results, 25, 26 and 21 patients were classified as ‘optimal’, respectively. Our results show a significant reduction in the achievement rate of ‘optimal’ for a CDR when the bladder volume is <100 cm(3). The total numbers of monitoring units (MUs) (average ± 1σ) were 469 ± 53, 357 ± 35 and 365 ± 33; the average optimization times were ∼50 min, 2 h and 2 h 40 min, and the irradiation times were ∼280 s, 60 s and 110 s, respectively. CDR can reduce the total MUs and irradiation time compared with f-IMRT, and CDR has a lower initial cost compared with VMAT. Thus, for institutions that do not currently perform VMAT, CDR is a useful option. Additionally, in the context of patient identification, bladder volume may be useful. |
format | Online Article Text |
id | pubmed-4099990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-40999902014-08-12 Utility of Smart Arc CDR for intensity-modulated radiation therapy for prostate cancer Hatanaka, Shogo Tamaki, Seiichi Endo, Haruna Mizuno, Norifumi Nakamura, Naoki J Radiat Res Oncology Volumetric-modulated arc therapy (VMAT) is a widespread intensity-modulated radiation therapy (IMRT) method, however, VMAT requires adaptation of the radiation treatment planning system (RTPS) and linear accelerator (linac); these upgrades are quite expensive. The Smart Arc of Pinnacle(3) (Philips), which is the software used in VMAT calculations, can select constant dose rate (CDR) mode. This approach has a low initial cost because the linac upgrade is not required. The objective of this study was to clarify the utility of CDR mode for prostate IMRT. Pinnacle(3) and Clinac 21EX linac (Varian, 10 MV X-rays) were used for planning. The plans were created for 28 patients using a fixed multi-field IMRT (f-IMRT), VMAT and CDR techniques. The dose distribution results were classified into three groups: optimal, suboptimal and reject. For the f-IMRT, VMAT and CDR results, 25, 26 and 21 patients were classified as ‘optimal’, respectively. Our results show a significant reduction in the achievement rate of ‘optimal’ for a CDR when the bladder volume is <100 cm(3). The total numbers of monitoring units (MUs) (average ± 1σ) were 469 ± 53, 357 ± 35 and 365 ± 33; the average optimization times were ∼50 min, 2 h and 2 h 40 min, and the irradiation times were ∼280 s, 60 s and 110 s, respectively. CDR can reduce the total MUs and irradiation time compared with f-IMRT, and CDR has a lower initial cost compared with VMAT. Thus, for institutions that do not currently perform VMAT, CDR is a useful option. Additionally, in the context of patient identification, bladder volume may be useful. Oxford University Press 2014-07 2014-02-11 /pmc/articles/PMC4099990/ /pubmed/24522268 http://dx.doi.org/10.1093/jrr/rrt232 Text en © The Author 2014. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Oncology Hatanaka, Shogo Tamaki, Seiichi Endo, Haruna Mizuno, Norifumi Nakamura, Naoki Utility of Smart Arc CDR for intensity-modulated radiation therapy for prostate cancer |
title | Utility of Smart Arc CDR for intensity-modulated radiation therapy for prostate cancer |
title_full | Utility of Smart Arc CDR for intensity-modulated radiation therapy for prostate cancer |
title_fullStr | Utility of Smart Arc CDR for intensity-modulated radiation therapy for prostate cancer |
title_full_unstemmed | Utility of Smart Arc CDR for intensity-modulated radiation therapy for prostate cancer |
title_short | Utility of Smart Arc CDR for intensity-modulated radiation therapy for prostate cancer |
title_sort | utility of smart arc cdr for intensity-modulated radiation therapy for prostate cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099990/ https://www.ncbi.nlm.nih.gov/pubmed/24522268 http://dx.doi.org/10.1093/jrr/rrt232 |
work_keys_str_mv | AT hatanakashogo utilityofsmartarccdrforintensitymodulatedradiationtherapyforprostatecancer AT tamakiseiichi utilityofsmartarccdrforintensitymodulatedradiationtherapyforprostatecancer AT endoharuna utilityofsmartarccdrforintensitymodulatedradiationtherapyforprostatecancer AT mizunonorifumi utilityofsmartarccdrforintensitymodulatedradiationtherapyforprostatecancer AT nakamuranaoki utilityofsmartarccdrforintensitymodulatedradiationtherapyforprostatecancer |